Atlas Trials

Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity

Clinical trial NCT00481559 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT00481559
Sponsor
BTG International Inc.
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Neoplasms

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.